Digital Body Mindset Intervention for Young Cancer Survivors
Launched by KING'S COLLEGE LONDON · Nov 20, 2024
Trial Information
Current as of August 21, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a program called EMBody, which is designed to help young cancer survivors aged 16 to 25 improve their mindset and overall well-being after finishing their cancer treatment. The study aims to find out if this digital program can help these young people feel better both physically and mentally by encouraging healthier ways of thinking about their bodies and health.
To be eligible for the trial, participants must be between 16 and 25 years old, have a history of cancer (like leukemia or lymphoma), and must have completed their main cancer treatment within the last seven years. Participants should not have any serious cognitive issues that would make it hard for them to use the program or be currently undergoing cancer treatment. If you choose to take part, you’ll be involved in using the EMBody program and sharing your experiences, which can help researchers understand how to better support young cancer survivors in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Ages 16-25 years
- • Previously received a cancer diagnosis including but not limited to leukemia, Hodgkins/non-Hodgkins lymphoma, osteosarcoma, Ewing sarcoma, or CNS tumour
- • Completed active, primary cancer treatment
- • Are up to seven years off treatment
- Exclusion Criteria:
- • Significant cognitive impairment that would interfere with engagement with digital materials
- • Not able read or write in English
- • Active suicidal intent
- • Currently receiving active treatment for primary or secondary cancer
- • Completed cancer treatment more than seven years ago
About King's College London
King's College London is a prominent research institution renowned for its commitment to advancing healthcare through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the college leverages its extensive expertise in medicine, neuroscience, and public health to conduct rigorous studies aimed at improving patient outcomes. As a sponsor of clinical trials, King's College London prioritizes ethical standards, participant safety, and scientific integrity, fostering an environment that encourages groundbreaking research and the translation of findings into clinical practice. Through its state-of-the-art facilities and a diverse network of researchers, the institution strives to address critical health challenges and contribute to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
London, , United Kingdom
Patients applied
Trial Officials
Lauren C Heathcote, PhD
Principal Investigator
King's College London
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported